Peptide record

TPDB10418

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity standard
24 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10418
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 Antifungipept CAFPdb i2APP AI4AVP dbAMP 3.0 DRAVP 2.0 ToxinPred 3.0
standard
No
A 24-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
LLKELWTKIKGAGKAVLGKIKGLL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C123H217N31O28
RNDCQHMFPSY
LK
2578.27
10.82
6
1
12
+5
-0.43
0.396
150.42
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
5500
2.13
1
Residue Composition
number
2
A
0
R
0
N
0
D
0
C
1
E
0
Q
4
G
0
H
2
I
6
L
6
K
0
M
0
F
0
P
0
S
1
T
1
W
0
Y
1
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 4 H: 0 I: 2 L: 6 K: 6 M: 0 F: 0 P: 0 S: 0 T: 1 W: 1 Y: 0 V: 1
Chemical Descriptors
24 reviewed residue count
C123H217N31O28 sequence-only estimate (linear, free termini)
2578.27 sequence-only estimate (linear, free termini)
10.82 sequence-only estimate (linear, free termini)
+5 sequence-only estimate (linear, free termini)
-0.43 sequence-only estimate (linear, free termini)
0.396 sequence-only estimate (linear, free termini)
Evidence Records 15 records
Evidence 1 Activity

Activity

MIC
Antibacterial
2-85 µM

Target

Staphylococcus aureus CIP 677 MRSA

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
CIP A22. MIC measurement: active against L. lactis ssp. cremoris I 116 (MIC < 0.125 uM), S. aureus CIP 677 MRSA (MIC 2-85 uM), Gram- E. coli L2, K. pneumoniae CIP 8291 (MIC 2-4 uM), P. putida LMA (16-32 uM), and S.
Evidence 2 Activity

Activity

MIC
Antibacterial
2-4 µM

Target

Klebsiella pneumoniae CIP 8291

Source & Reference

dbAMP DRAMP

Other

cremoris I 116 (MIC < 0.125 uM), S. aureus CIP 677 MRSA (MIC 2-85 uM), Gram- E. coli L2, K. pneumoniae CIP 8291 (MIC 2-4 uM), P. putida LMA (16-32 uM), and S. enterica CIP 813 (MIC 8-16 uM).
Evidence 3 Activity

Activity

MIC
Antibacterial
8-16 µM

Target

S. enterica CIP 813

Source & Reference

dbAMP DRAMP

Other

uM), Gram- E. coli L2, K. pneumoniae CIP 8291 (MIC 2-4 uM), P. putida LMA (16-32 uM), and S. enterica CIP 813 (MIC 8-16 uM).
Evidence 4 Activity

Activity

MIC
Antifungal
2-85 µM

Target

Staphylococcus aureus CIP 677 MRSA

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
CIP A22. MIC measurement: active against L. lactis ssp. cremoris I 116 (MIC < 0.125 uM), S. aureus CIP 677 MRSA (MIC 2-85 uM), Gram- E. coli L2, K. pneumoniae CIP 8291 (MIC 2-4 uM), P. putida LMA (16-32 uM), and S.
Evidence 5 Activity

Activity

MIC
Antifungal
2-4 µM

Target

Klebsiella pneumoniae CIP 8291

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

cremoris I 116 (MIC < 0.125 uM), S. aureus CIP 677 MRSA (MIC 2-85 uM), Gram- E. coli L2, K. pneumoniae CIP 8291 (MIC 2-4 uM), P. putida LMA (16-32 uM), and S. enterica CIP 813 (MIC 8-16 uM).
Evidence 6 Activity

Activity

MIC
Antifungal
8-16 µM

Target

S. enterica CIP 813

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

uM), Gram- E. coli L2, K. pneumoniae CIP 8291 (MIC 2-4 uM), P. putida LMA (16-32 uM), and S. enterica CIP 813 (MIC 8-16 uM).
Evidence 7 Activity

Activity

MIC
Antiparasitic
2-85 µM

Target

Staphylococcus aureus CIP 677 MRSA

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
CIP A22. MIC measurement: active against L. lactis ssp. cremoris I 116 (MIC < 0.125 uM), S. aureus CIP 677 MRSA (MIC 2-85 uM), Gram- E. coli L2, K. pneumoniae CIP 8291 (MIC 2-4 uM), P. putida LMA (16-32 uM), and S.
Evidence 8 Activity

Activity

MIC
Antiparasitic
2-4 µM

Target

Klebsiella pneumoniae CIP 8291

Source & Reference

dbAMP 3.0 DRAMP

Other

cremoris I 116 (MIC < 0.125 uM), S. aureus CIP 677 MRSA (MIC 2-85 uM), Gram- E. coli L2, K. pneumoniae CIP 8291 (MIC 2-4 uM), P. putida LMA (16-32 uM), and S. enterica CIP 813 (MIC 8-16 uM).
Evidence 9 Activity

Activity

MIC
Antiparasitic
8-16 µM

Target

S. enterica CIP 813

Source & Reference

dbAMP 3.0 DRAMP

Other

uM), Gram- E. coli L2, K. pneumoniae CIP 8291 (MIC 2-4 uM), P. putida LMA (16-32 uM), and S. enterica CIP 813 (MIC 8-16 uM).
Evidence 10 Activity

Activity

MIC
Antiviral
2-85 µM

Target

Staphylococcus aureus CIP 677 MRSA

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets. dbAMP 3.0 classified under the Anti-viral function class.
CIP A22. MIC measurement: active against L. lactis ssp. cremoris I 116 (MIC < 0.125 uM), S. aureus CIP 677 MRSA (MIC 2-85 uM), Gram- E. coli L2, K. pneumoniae CIP 8291 (MIC 2-4 uM), P. putida LMA (16-32 uM), and S.
Evidence 11 Activity

Activity

MIC
Antiviral
2-4 µM

Target

Klebsiella pneumoniae CIP 8291

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

cremoris I 116 (MIC < 0.125 uM), S. aureus CIP 677 MRSA (MIC 2-85 uM), Gram- E. coli L2, K. pneumoniae CIP 8291 (MIC 2-4 uM), P. putida LMA (16-32 uM), and S. enterica CIP 813 (MIC 8-16 uM).
Evidence 12 Activity

Activity

MIC
Antiviral
8-16 µM

Target

S. enterica CIP 813

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

uM), Gram- E. coli L2, K. pneumoniae CIP 8291 (MIC 2-4 uM), P. putida LMA (16-32 uM), and S. enterica CIP 813 (MIC 8-16 uM).
Evidence 13 Activity

Activity

Toxicity
Hemolytic Cytotoxic
- | NA | target cell: Horse erythrocytes

Target

Horse erythrocytes

Source & Reference

NA
DBAASP
Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. | J Biol Chem | 2001
Evidence 14 Activity

Activity

Toxicity
Hemolytic Cytotoxic
- | NA | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. | J Biol Chem | 2001
Evidence 15 Activity

Activity

50% Cell death
Toxicity
24.7 µM
Cytotoxic
50% Cell death | 24.7 | µM | target cell: CEM-SS cells

Target

CEM-SS cells

Source & Reference

NA
DBAASP
Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database. | Antimicrob Agents Chemother | 2010